DEA CME Requirements 2026: What's Changed and What You Need

If you prescribe controlled substances, understanding the current DEA CME requirements is not optional. The regulatory landscape for opioid prescribers has shifted significantly since the Medication Access and Training Expansion (MATE) Act took effect in June 2023, and 2026 marks a critical year for practitioners wh...

DEA CME Requirements 2026: What's Changed and What You Need

DEA CME Requirements in 2026: The Full Picture

If you prescribe controlled substances, understanding the current DEA CME requirements is not optional. The regulatory landscape for opioid prescribers has shifted significantly since the Medication Access and Training Expansion (MATE) Act took effect in June 2023, and 2026 marks a critical year for practitioners who have not yet completed their mandatory training. Whether you are renewing your DEA registration for the first time under these rules or verifying that your previous training still qualifies, this guide covers every detail you need.

The current federal training obligations now center on a one-time, eight-hour mandate that applies to virtually every practitioner who holds a DEA registration. This federal requirement exists alongside state-level opioid prescriber education mandates that vary widely in scope and hours. Meeting both layers of obligation is essential to maintaining your prescribing privileges and avoiding regulatory action.

This article breaks down exactly what the 2026 DEA CME requirements entail, which practitioners must comply, where to find approved training, and how the American Academy of Procedural Medicine (AAOPM) can help you satisfy these obligations while gaining advanced clinical skills in pain management and opioid prescribing.

The MATE Act: Federal Training Mandate Explained

The Medication Access and Training Expansion Act, commonly called the MATE Act, was enacted as part of the Consolidated Appropriations Act of 2023. It replaced the previous DATA-waiver (X-waiver) system that had governed buprenorphine prescribing since 2000. The MATE Act fundamentally changed how the DEA approaches prescriber education by broadening the training requirement to all DEA-registered practitioners, not just those seeking to prescribe buprenorphine.

Under the MATE Act, every practitioner applying for a new DEA registration or renewing an existing one on or after June 27, 2023, must attest to completing at least eight hours of training on opioid and other substance use disorders. This includes training on the treatment and management of patients with substance use disorders, the appropriate clinical use of all FDA-approved medications for treating substance use disorders, and safe prescribing practices for controlled substances.

Why the MATE Act Replaced the X-Waiver

The X-waiver system created a bottleneck in addiction treatment access. Only practitioners who completed the waiver training and applied for a separate DEA designation could prescribe buprenorphine. The MATE Act eliminated the X-waiver requirement entirely, allowing any DEA-registered practitioner to prescribe buprenorphine within their scope of practice. In exchange, the law imposed universal training requirements on all controlled substance prescribers to ensure baseline competency in substance use disorder recognition and treatment.

This shift reflects the federal government's recognition that every prescriber, regardless of specialty, needs foundational knowledge in safe opioid prescribing and substance use disorder management. The DEA CME requirements under the MATE Act are designed to close that knowledge gap across the entire prescriber workforce.

What Changed for 2026 DEA Registration Renewals

For practitioners renewing their DEA registration in 2026, the key development is straightforward: if you have not yet completed the eight-hour training, your 2026 renewal is likely the deadline. DEA registrations renew on a three-year cycle. Practitioners whose registrations renewed shortly before June 27, 2023, are now reaching their first renewal under the MATE Act rules in 2025 or 2026.

The One-Time Nature of the Requirement

An important distinction in the current DEA CME requirements is that the eight-hour MATE Act training is a one-time obligation. Once you complete the training and attest to it during your DEA registration, you do not need to repeat it for subsequent renewals. However, you must complete the training after June 27, 2023, for it to count. Training completed before that date does not satisfy the requirement unless it was an approved X-waiver course completed on or after the effective date.

2026 Regulatory Updates to Monitor

While the core eight-hour requirement remains unchanged for 2026, several regulatory developments are worth tracking:

• DEA enforcement posture: The DEA has signaled increased scrutiny of attestation accuracy. Practitioners who attest to completing training without documentation may face audit inquiries.
• State-level expansions: Several states are considering additional opioid prescriber education mandates that go beyond the federal eight-hour minimum.
• SAMHSA guidance updates: SAMHSA continues to refine its resource pages and training provider lists, offering practitioners clearer pathways to compliance.
• Expanded training content: Newer courses approved for MATE Act compliance increasingly incorporate non-opioid pain management strategies, multimodal approaches, and updated CDC clinical practice guidelines.

Staying current with these evolving training mandates is particularly important for practitioners in states that layer additional obligations on top of the federal requirement.

The Eight-Hour Training Requirement in Detail

The eight-hour training mandated by the MATE Act must cover specific content areas defined in the legislation. Understanding what the training must include helps you select a program that fully satisfies the DEA CME requirements rather than one that falls short.

Required Training Content Areas

According to the Consolidated Appropriations Act and SAMHSA guidance, compliant training must address:

• Treatment and management of patients with opioid use disorders and other substance use disorders
• Identification of patients at risk for substance use disorders
• Evidence-based pharmacotherapy for substance use disorders, including all FDA-approved medications
• Safe prescribing practices for controlled substances, including opioid tapering and discontinuation strategies
• Recognition and management of opioid overdose, including naloxone administration
• Non-opioid and multimodal pain management alternatives
• Patient communication strategies around pain, addiction, and treatment options

Flexible Completion Options

The training does not need to be completed in a single eight-hour session. Practitioners can accumulate the required hours across multiple courses and activities, as long as all training is obtained from approved providers and the total reaches eight hours. This flexibility makes it practical for busy clinicians to fit the required training into their schedules without disrupting patient care.

Who Must Comply and Who Is Exempt

The MATE Act training requirement applies broadly, but specific exemptions exist. Knowing where you fall is essential before investing time and money in training you may not need.

Practitioners Who Must Complete Training

All DEA-registered practitioners who prescribe Schedule II through Schedule V controlled substances must complete the eight-hour training. This includes physicians (MD and DO), nurse practitioners, physician assistants, certified registered nurse anesthetists, certified nurse midwives, dentists, podiatrists, and optometrists with prescribing authority. The requirement applies regardless of whether you prescribe opioids specifically; if you hold a DEA registration, you must comply.

Exemptions from the Training Requirement

The following practitioners are exempt from the DEA CME requirements under the MATE Act:

• Veterinarians: Practitioners who exclusively practice veterinary medicine are fully exempt.
• Board-certified addiction specialists: Those holding current board certification in addiction medicine from the American Board of Preventive Medicine or addiction psychiatry from the American Board of Psychiatry and Neurology are exempt.
• Recent graduates: Practitioners who graduated within the past five years from a qualifying U.S. medical, nursing, or physician assistant program whose curriculum included at least eight hours of substance use disorder education are exempt.
• Previous X-waiver holders: Practitioners who completed approved DATA-waiver training before the MATE Act took effect may qualify, depending on when and how their training was completed.

Even if you qualify for an exemption, you must still attest to your exempt status when applying for or renewing your DEA registration. The DEA does not automatically recognize exemptions without your declaration.

State-Specific Opioid CME Requirements Beyond the DEA

The federal DEA CME requirements represent the floor, not the ceiling. Many states impose their own opioid prescriber education mandates that run in parallel with the MATE Act. Failing to meet your state's requirements can result in disciplinary action from your state medical board, even if you are fully compliant with the federal training.

States with Additional Opioid CME Mandates

As of 2026, the following states require opioid-specific continuing education beyond the federal eight-hour minimum. Hours listed are per licensing cycle unless noted otherwise:

• California: 12 hours of pain management and end-of-life care CME (one-time for initial licensure)
• Connecticut: 1 hour of prescribing controlled substances training per registration period
• Florida: 2 hours of controlled substance prescribing education per biennial renewal
• Georgia: 3 hours of controlled substances prescribing practices per renewal
• Illinois: 3 hours of safe opioid prescribing practices per renewal cycle
• Indiana: 2 hours of opioid prescribing and abuse education per renewal
• Massachusetts: 3 hours of pain management CME per two-year cycle
• Nevada: 2 hours of controlled substance misuse and abuse training per renewal
• New Hampshire: 3 hours of opioid prescribing CME per renewal period
• New York: 3 hours of pain management, palliative care, and addiction CME per three-year cycle
• Pennsylvania: 4 hours total (2 hours in pain management and 2 hours in opioid prescribing practices)
• West Virginia: 3 hours of opioid prescribing CME per licensing period

Several states, including Hawaii, Idaho, Kansas, Missouri, Montana, North Dakota, and South Dakota, do not currently impose state-specific opioid CME requirements beyond the federal MATE Act mandate. Check your state medical board's website for the most current information, as requirements change frequently.

Dual Compliance Strategy

The most efficient approach is to select training programs that simultaneously satisfy both federal DEA CME requirements and your state-specific mandates. Many ACCME-accredited opioid education courses are designed with dual compliance in mind, and programs offered through organizations like AAOPM structure their curricula to address both layers of regulation.

Approved Training Providers and Accreditation Bodies

Not all opioid education counts toward the federal training mandate. The MATE Act specifies which organizations can approve or provide qualifying training. Completing a course from a non-qualifying provider wastes your time and leaves you noncompliant.

Organizations Named in the MATE Act

The Consolidated Appropriations Act specifically names the following accrediting and training organizations:

• ACCME (Accreditation Council for Continuing Medical Education): Any organization accredited by ACCME to provide continuing medical education can offer MATE Act-compliant training.
• AOA (American Osteopathic Association): Organizations accredited by the AOA for continuing medical education qualify.
• ASAM (American Society of Addiction Medicine): ASAM is both named in the Act and accredited by ACCME, offering multiple eight-hour training pathways.
• AMA (American Medical Association): The AMA Ed Hub provides free training modules that satisfy the full eight-hour requirement.
• AAAP (American Academy of Addiction Psychiatry): Offers accredited training in substance use disorder management.
• AAFP (American Academy of Family Physicians): Provides MATE Act-compliant education through its CME platform.

Important Accreditation Verification

When selecting a training program, verify that it carries AMA PRA Category 1 Credit designation or equivalent accreditation from an AOA-approved provider. SAMHSA and the DEA do not independently review or approve training content. The responsibility for ensuring your training comes from a qualifying source rests with you as the practitioner. Always confirm accreditation before beginning a course to ensure it will count toward your federal opioid training obligation.

How to Complete Your DEA CME Training

With dozens of training options available, choosing the right pathway depends on your learning style, specialty focus, budget, and schedule. Here is a practical framework for completing your training efficiently.

Step 1: Determine Your Compliance Status

Check your DEA registration expiration date. If your next renewal falls in 2026, you must have eight hours of qualifying training completed before you submit your renewal application. Log in to the DEA Diversion Control Division portal to verify your registration details.

Step 2: Review Your Existing Training

Audit your CME records for any opioid, substance use disorder, or pain management education completed since June 27, 2023. Courses from ACCME-accredited providers that covered the required content areas count toward your eight-hour total, even if they were not specifically labeled as MATE Act training.

Step 3: Select Your Training Format

Training is available in several formats:

• Self-paced online courses: Complete at your convenience over days or weeks. Ideal for practitioners with unpredictable schedules.
• Live virtual sessions: Structured online instruction with real-time interaction and faculty Q&A.
• In-person workshops: Hands-on training that combines didactic instruction with clinical practice. Programs from organizations like AAOPM pair opioid education with procedural pain management skills.
• Blended programs: Combine online didactic modules with in-person clinical components for comprehensive learning.

Step 4: Complete and Document Your Training

Retain your CME certificates and course completion records. While the DEA does not require you to submit documentation at the time of renewal, you must be able to produce proof of training if audited. Store digital copies of all certificates in a secure, accessible location.

Documentation and Compliance Verification

The DEA's compliance model for the MATE Act is attestation-based. When you apply for or renew your DEA registration, you will check a box confirming that you have completed the required training. The DEA does not collect certificates or transcripts at the point of registration. However, this does not mean documentation is unimportant.

What to Keep on File

Maintain the following records for each course that contributes to your training obligation:

• Course title and provider name
• Date of completion
• Number of CME credits awarded
• Accreditation statement (ACCME, AOA, or equivalent)
• Certificate of completion
• Course content description or syllabus confirming coverage of required topic areas

Audit Preparedness

The DEA has the authority to request documentation at any time. False attestation on a DEA registration application is a federal offense. Treat your training records with the same seriousness you apply to state medical license documentation. If you completed training through multiple providers, create a summary log that shows how your total hours break down across courses and content areas.

Consequences of Noncompliance

Failing to meet the federal training requirements carries real consequences that can disrupt your practice and career.

Federal Consequences

If you attest to completing training without actually doing so, you are making a false statement on a federal application. This can result in denial or revocation of your DEA registration, civil penalties, and in extreme cases, criminal prosecution. Even an honest oversight, such as completing training from a non-qualifying provider, can result in a registration delay while you complete compliant education.

State-Level Consequences

State medical boards may take independent disciplinary action for failure to meet state opioid CME mandates. Consequences range from warning letters and fines to license suspension. In states with robust enforcement, noncompliance can also trigger mandatory remediation plans that require additional education hours beyond the original requirement.

Practice Impact

A lapsed or denied DEA registration means you cannot prescribe controlled substances. For many specialties, this effectively halts clinical practice. Hospital credentialing committees and insurance panels may also flag noncompliance as a reason to deny or revoke privileges.

AAOPM Pain Management and Opioid Training Programs

The American Academy of Procedural Medicine (AAOPM) offers CME-accredited training programs that address both the DEA CME requirements and the clinical skills gap that many prescribers face in pain management. Unlike training that focuses exclusively on meeting regulatory minimums, AAOPM's programs equip practitioners with practical, procedure-ready competencies.

Beyond Compliance: Clinical Pain Management Skills

AAOPM's pain management curriculum covers opioid pharmacology and safe prescribing practices alongside interventional and multimodal treatment approaches. This means you can satisfy your federal and state training obligations while simultaneously gaining skills in areas like joint injection techniques, trigger point therapy, regenerative medicine applications, and comprehensive pain assessment methodologies.

Why Practitioners Choose AAOPM

• CME-accredited: All applicable AAOPM courses carry continuing medical education credits from recognized accrediting bodies.
• Hands-on training: In-person courses include live procedural practice under expert supervision, giving you skills that online-only programs cannot provide.
• Weekend scheduling: Training sessions are designed for working clinicians, minimizing time away from your practice.
• Comprehensive curriculum: AAOPM's course catalog spans pain management, anti-aging medicine, regenerative therapies, and more, allowing you to build a full clinical toolkit.
• Modular investment: Start with individual courses and build toward full certification at your own pace and budget.

Integrating DEA Compliance with Practice Growth

Meeting your DEA CME requirements should not be a box-checking exercise. The most effective approach treats mandatory training as an opportunity to expand your clinical capabilities and your practice's service offerings. Practitioners who complete AAOPM's pain management training consistently report that their compliance education directly translates into new patient services and revenue streams. Explore AAOPM's available programs to see how compliance and clinical growth can work together.

Frequently Asked Questions

Is the DEA eight-hour MATE Act training a one-time or recurring requirement?

The MATE Act training is a one-time requirement. Once you complete eight hours of qualifying training and attest to it on your DEA registration application, you do not need to repeat it for future renewals. However, you should continue to meet any separate state-level opioid CME mandates, which are typically recurring requirements tied to your state licensing cycle. The one-time federal training mandate and ongoing state obligations are independent of each other.

What happens if I do not complete the training before my DEA renewal in 2026?

You will be unable to truthfully attest to compliance on your DEA renewal application. Submitting a renewal without attesting to training completion may result in processing delays, and falsely attesting to training you have not completed constitutes a federal offense. If your renewal date is approaching and you have not yet completed the training, prioritize enrolling in an approved course immediately. Many online programs allow you to complete all eight hours in a single day.

Can I use opioid CME from my state requirements to satisfy the federal DEA training?

In many cases, yes. If your state-required opioid CME was completed after June 27, 2023, covers the content areas specified in the MATE Act, and was provided by an ACCME-accredited or otherwise qualifying organization, those hours can count toward your federal eight-hour total. Review the specific content of your state-mandated training against the MATE Act requirements to confirm overlap. Courses that focus narrowly on state prescribing regulations without addressing substance use disorder treatment may not fully satisfy the federal DEA CME requirements.

Do I need to submit my training certificates to the DEA?

No. The DEA does not collect training certificates or transcripts at the time of registration or renewal. The compliance model is attestation-based, meaning you check a box confirming you have met the requirement. However, you must retain your documentation and be prepared to produce it if the DEA requests verification. Keep certificates from all qualifying courses in a secure file for at least the duration of your current registration period.

Which online courses satisfy the DEA CME requirements for the least cost?

Several organizations offer free or low-cost training that meets the full eight-hour requirement. The AMA Ed Hub provides a free course bundle. Boston Medical Center's Addiction Training program offers free MATE Act-compliant training. NEJM Group provides a comprehensive course at no cost. Pri-Med offers free opioid CME modules. While these free options satisfy the minimum DEA CME requirements, paid programs from organizations like AAOPM provide deeper clinical training and hands-on skills that free compliance-focused courses do not.

Are nurse practitioners and physician assistants subject to the same DEA CME requirements as physicians?

Yes. The MATE Act applies equally to all DEA-registered practitioners with prescribing authority for Schedule II through Schedule V controlled substances. This includes nurse practitioners, physician assistants, certified registered nurse anesthetists, certified nurse midwives, dentists, podiatrists, and optometrists with controlled substance prescribing privileges. The eight-hour training requirement and content standards are identical regardless of your practitioner type. The only exception is veterinarians, who are fully exempt from the DEA CME requirements under the MATE Act.

How do I verify that a training course qualifies for the MATE Act requirement?

Confirm that the course provider is accredited by the ACCME, the AOA, or one of the other organizations specifically named in Section 1263 of the Consolidated Appropriations Act of 2023. Check that the course content addresses the treatment and management of substance use disorders, including FDA-approved pharmacotherapies, safe prescribing practices, and patient risk identification. If the course description does not explicitly reference MATE Act compliance or DEA training requirements, contact the provider directly to verify before enrolling.

Secure Your DEA Registration: Next Steps

The DEA CME requirements under the MATE Act are not going away, and the consequences of noncompliance are too significant to ignore. If you have not yet completed your eight-hour training obligation, 2026 is the year to act, especially if your DEA registration is up for renewal.

Rather than treating this as a regulatory burden, use it as a catalyst for professional growth. AAOPM's pain management training programs let you meet your federal and state compliance obligations while gaining hands-on clinical skills that directly benefit your patients and your practice.

Explore AAOPM's CME-Accredited Training Programs to find courses that satisfy your DEA CME requirements and expand your pain management capabilities. Visit the full course catalog to see upcoming sessions, or contact AAOPM's enrollment team to discuss which training pathway aligns with your compliance needs and clinical goals.